S5613 A Case Report: Drug-Induced Liver Injury from Prolonged Topical Application of Noni (Morinda citrifolia)

Introduction: Noni (Morinda citrifolia) is a plant-based supplement that has antioxidant, anti-inflammatory and immunomodulating effects. It can be found in many formulations including oral supplements, juice, topical ointments. There have been sparse case reports on the juice and oral supplementations of Noni associated with transaminitis. However, there have been no reported instances of transaminitis linked to the topical use of Noni. Case Description/Methods: We present a case of a 60-year-old man with a history of hypertension and hypothyroidism presented with jaundice, generalized pruritus, dark yellow urine, and acholic stools persisting for 5 days. Laboratory findings revealed elevated liver enzymes and a cholestatic pattern of injury. The patient had used a topical Morinda citrifolia-based analgesic cream for 8 months before discontinuing it 3 months prior to the onset of symptoms. Extensive diagnostic evaluation excluded viral, autoimmune, and metabolic causes of liver dysfunction, leading to a diagnosis of drug-induced liver injury secondary to the prolonged use of Noni products. Patient was closely monitored outpatient after discontinuation of topical Noni with normalization of the liver function tests within 6 months. Discussion: The elevation of liver enzymes secondary to the use of topical Noni is exceptionally rare in literature. Prior case reports showed the association through systemic means of absorption, but not through topical use. This case highlights the hepatotoxic potential of Morinda citrifolia, with topical application, and the importance of recognizing herbal products as potential contributors to liver injury. While the true mechanism of hepatotoxicity is not fully understood, one proposed mechanism could be anthraquinones' induced production of reactive oxygen species leading to the disruption of mitochondrial respiration, impairment energy production in hepatocytes that leads to cell apoptosis or necrosis. Further studies are needed to delineate the mechanism of absorption and toxicity for topical noni products.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001149912.56912.0c
Primary Topic
Morinda citrifolia extract uses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S5613 A Case Report: Drug-Induced Liver Injury from Prolonged Topical Application of Noni (Morinda citrifolia)

Charles Kim, Jonathan Vincent M. Reyes, Kelly Brennan, Samuel H. Huang et al.
The American Journal of Gastroenterology
Morinda citrifolia extract uses
article

S5613 A Case Report: Drug-Induced Liver Injury from Prolonged Topical Application of Noni (Morinda citrifolia)

Charles Kim, Jonathan Vincent M. Reyes, Kelly Brennan, Samuel H. Huang, Diego J. Duran Baez, Mahnoor Khan, Lenura Ziyadin
article en

Abstract

Introduction: Noni (Morinda citrifolia) is a plant-based supplement that has antioxidant, anti-inflammatory and immunomodulating effects. It can be found in many formulations including oral supplements, juice, topical ointments. There have been sparse case reports on the juice and oral supplementations of Noni associated with transaminitis. However, there have been no reported instances of transaminitis linked to the topical use of Noni. Case Description/Methods: We present a case of a 60-year-old man with a history of hypertension and hypothyroidism presented with jaundice, generalized pruritus, dark yellow urine, and acholic stools persisting for 5 days. Laboratory findings revealed elevated liver enzymes and a cholestatic pattern of injury. The patient had used a topical Morinda citrifolia-based analgesic cream for 8 months before discontinuing it 3 months prior to the onset of symptoms. Extensive diagnostic evaluation excluded viral, autoimmune, and metabolic causes of liver dysfunction, leading to a diagnosis of drug-induced liver injury secondary to the prolonged use of Noni products. Patient was closely monitored outpatient after discontinuation of topical Noni with normalization of the liver function tests within 6 months. Discussion: The elevation of liver enzymes secondary to the use of topical Noni is exceptionally rare in literature. Prior case reports showed the association through systemic means of absorption, but not through topical use. This case highlights the hepatotoxic potential of Morinda citrifolia, with topical application, and the importance of recognizing herbal products as potential contributors to liver injury. While the true mechanism of hepatotoxicity is not fully understood, one proposed mechanism could be anthraquinones' induced production of reactive oxygen species leading to the disruption of mitochondrial respiration, impairment energy production in hepatocytes that leads to cell apoptosis or necrosis. Further studies are needed to delineate the mechanism of absorption and toxicity for topical noni products.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 44%
Morinda citrifolia extract uses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.